Antihypertensive Agents and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Antihypertensive Agents Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antihypertensive Agents Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antihypertensive Agents Overall Market Size
2.1 Global Antihypertensive Agents Market Size: 2022 VS 2029
2.2 Global Antihypertensive Agents Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antihypertensive Agents Players in Global Market
3.2 Top Global Antihypertensive Agents Companies Ranked by Revenue
3.3 Global Antihypertensive Agents Revenue by Companies
3.4 Top 3 and Top 5 Antihypertensive Agents Companies in Global Market, by Revenue in 2022
3.5 Global Companies Antihypertensive Agents Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antihypertensive Agents Players in Global Market
3.6.1 List of Global Tier 1 Antihypertensive Agents Companies
3.6.2 List of Global Tier 2 and Tier 3 Antihypertensive Agents Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Antihypertensive Agents Market Size Markets, 2022 & 2029
4.1.2 Thiazide Diuretics
4.1.3 Calcium Channel Blockers (CCB)
4.1.4 ACE Inhibitors
4.1.5 Angiotensin II Receptor Antagonists (ARBs)
4.2 By Type - Global Antihypertensive Agents Revenue & Forecasts
4.2.1 By Type - Global Antihypertensive Agents Revenue, 2018-2023
4.2.2 By Type - Global Antihypertensive Agents Revenue, 2024-2029
4.2.3 By Type - Global Antihypertensive Agents Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Antihypertensive Agents Market Size, 2022 & 2029
5.1.2 Children
5.1.3 Adult
5.2 By Application - Global Antihypertensive Agents Revenue & Forecasts
5.2.1 By Application - Global Antihypertensive Agents Revenue, 2018-2023
5.2.2 By Application - Global Antihypertensive Agents Revenue, 2024-2029
5.2.3 By Application - Global Antihypertensive Agents Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Antihypertensive Agents Market Size, 2022 & 2029
6.2 By Region - Global Antihypertensive Agents Revenue & Forecasts
6.2.1 By Region - Global Antihypertensive Agents Revenue, 2018-2023
6.2.2 By Region - Global Antihypertensive Agents Revenue, 2024-2029
6.2.3 By Region - Global Antihypertensive Agents Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Antihypertensive Agents Revenue, 2018-2029
6.3.2 US Antihypertensive Agents Market Size, 2018-2029
6.3.3 Canada Antihypertensive Agents Market Size, 2018-2029
6.3.4 Mexico Antihypertensive Agents Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Antihypertensive Agents Revenue, 2018-2029
6.4.2 Germany Antihypertensive Agents Market Size, 2018-2029
6.4.3 France Antihypertensive Agents Market Size, 2018-2029
6.4.4 U.K. Antihypertensive Agents Market Size, 2018-2029
6.4.5 Italy Antihypertensive Agents Market Size, 2018-2029
6.4.6 Russia Antihypertensive Agents Market Size, 2018-2029
6.4.7 Nordic Countries Antihypertensive Agents Market Size, 2018-2029
6.4.8 Benelux Antihypertensive Agents Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Antihypertensive Agents Revenue, 2018-2029
6.5.2 China Antihypertensive Agents Market Size, 2018-2029
6.5.3 Japan Antihypertensive Agents Market Size, 2018-2029
6.5.4 South Korea Antihypertensive Agents Market Size, 2018-2029
6.5.5 Southeast Asia Antihypertensive Agents Market Size, 2018-2029
6.5.6 India Antihypertensive Agents Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Antihypertensive Agents Revenue, 2018-2029
6.6.2 Brazil Antihypertensive Agents Market Size, 2018-2029
6.6.3 Argentina Antihypertensive Agents Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Antihypertensive Agents Revenue, 2018-2029
6.7.2 Turkey Antihypertensive Agents Market Size, 2018-2029
6.7.3 Israel Antihypertensive Agents Market Size, 2018-2029
6.7.4 Saudi Arabia Antihypertensive Agents Market Size, 2018-2029
6.7.5 UAE Antihypertensive Agents Market Size, 2018-2029
7 Antihypertensive Agents Companies Profiles
7.1 Baxter International
7.1.1 Baxter International Company Summary
7.1.2 Baxter International Business Overview
7.1.3 Baxter International Antihypertensive Agents Major Product Offerings
7.1.4 Baxter International Antihypertensive Agents Revenue in Global Market (2018-2023)
7.1.5 Baxter International Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Antihypertensive Agents Major Product Offerings
7.2.4 Pfizer Antihypertensive Agents Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Sandoz
7.3.1 Sandoz Company Summary
7.3.2 Sandoz Business Overview
7.3.3 Sandoz Antihypertensive Agents Major Product Offerings
7.3.4 Sandoz Antihypertensive Agents Revenue in Global Market (2018-2023)
7.3.5 Sandoz Key News & Latest Developments
7.4 Teva Pharmaceuticals
7.4.1 Teva Pharmaceuticals Company Summary
7.4.2 Teva Pharmaceuticals Business Overview
7.4.3 Teva Pharmaceuticals Antihypertensive Agents Major Product Offerings
7.4.4 Teva Pharmaceuticals Antihypertensive Agents Revenue in Global Market (2018-2023)
7.4.5 Teva Pharmaceuticals Key News & Latest Developments
7.5 Bayer
7.5.1 Bayer Company Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Antihypertensive Agents Major Product Offerings
7.5.4 Bayer Antihypertensive Agents Revenue in Global Market (2018-2023)
7.5.5 Bayer Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Antihypertensive Agents Major Product Offerings
7.6.4 Johnson & Johnson Antihypertensive Agents Revenue in Global Market (2018-2023)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 Sun Pharmaceutical Industries
7.7.1 Sun Pharmaceutical Industries Company Summary
7.7.2 Sun Pharmaceutical Industries Business Overview
7.7.3 Sun Pharmaceutical Industries Antihypertensive Agents Major Product Offerings
7.7.4 Sun Pharmaceutical Industries Antihypertensive Agents Revenue in Global Market (2018-2023)
7.7.5 Sun Pharmaceutical Industries Key News & Latest Developments
7.8 Merck
7.8.1 Merck Company Summary
7.8.2 Merck Business Overview
7.8.3 Merck Antihypertensive Agents Major Product Offerings
7.8.4 Merck Antihypertensive Agents Revenue in Global Market (2018-2023)
7.8.5 Merck Key News & Latest Developments
7.9 AstraZeneca
7.9.1 AstraZeneca Company Summary
7.9.2 AstraZeneca Business Overview
7.9.3 AstraZeneca Antihypertensive Agents Major Product Offerings
7.9.4 AstraZeneca Antihypertensive Agents Revenue in Global Market (2018-2023)
7.9.5 AstraZeneca Key News & Latest Developments
7.10 Daiichi Sankyo
7.10.1 Daiichi Sankyo Company Summary
7.10.2 Daiichi Sankyo Business Overview
7.10.3 Daiichi Sankyo Antihypertensive Agents Major Product Offerings
7.10.4 Daiichi Sankyo Antihypertensive Agents Revenue in Global Market (2018-2023)
7.10.5 Daiichi Sankyo Key News & Latest Developments
7.11 Takeda
7.11.1 Takeda Company Summary
7.11.2 Takeda Business Overview
7.11.3 Takeda Antihypertensive Agents Major Product Offerings
7.11.4 Takeda Antihypertensive Agents Revenue in Global Market (2018-2023)
7.11.5 Takeda Key News & Latest Developments
7.12 Actelion
7.12.1 Actelion Company Summary
7.12.2 Actelion Business Overview
7.12.3 Actelion Antihypertensive Agents Major Product Offerings
7.12.4 Actelion Antihypertensive Agents Revenue in Global Market (2018-2023)
7.12.5 Actelion Key News & Latest Developments
7.13 Viatris
7.13.1 Viatris Company Summary
7.13.2 Viatris Business Overview
7.13.3 Viatris Antihypertensive Agents Major Product Offerings
7.13.4 Viatris Antihypertensive Agents Revenue in Global Market (2018-2023)
7.13.5 Viatris Key News & Latest Developments
7.14 United Therapeutics
7.14.1 United Therapeutics Company Summary
7.14.2 United Therapeutics Business Overview
7.14.3 United Therapeutics Antihypertensive Agents Major Product Offerings
7.14.4 United Therapeutics Antihypertensive Agents Revenue in Global Market (2018-2023)
7.14.5 United Therapeutics Key News & Latest Developments
7.15 Lupin Limited
7.15.1 Lupin Limited Company Summary
7.15.2 Lupin Limited Business Overview
7.15.3 Lupin Limited Antihypertensive Agents Major Product Offerings
7.15.4 Lupin Limited Antihypertensive Agents Revenue in Global Market (2018-2023)
7.15.5 Lupin Limited Key News & Latest Developments
7.16 Hikma Pharmaceuticals
7.16.1 Hikma Pharmaceuticals Company Summary
7.16.2 Hikma Pharmaceuticals Business Overview
7.16.3 Hikma Pharmaceuticals Antihypertensive Agents Major Product Offerings
7.16.4 Hikma Pharmaceuticals Antihypertensive Agents Revenue in Global Market (2018-2023)
7.16.5 Hikma Pharmaceuticals Key News & Latest Developments
7.17 Aurobindo Pharma
7.17.1 Aurobindo Pharma Company Summary
7.17.2 Aurobindo Pharma Business Overview
7.17.3 Aurobindo Pharma Antihypertensive Agents Major Product Offerings
7.17.4 Aurobindo Pharma Antihypertensive Agents Revenue in Global Market (2018-2023)
7.17.5 Aurobindo Pharma Key News & Latest Developments
7.18 Camber Pharmaceutical
7.18.1 Camber Pharmaceutical Company Summary
7.18.2 Camber Pharmaceutical Business Overview
7.18.3 Camber Pharmaceutical Antihypertensive Agents Major Product Offerings
7.18.4 Camber Pharmaceutical Antihypertensive Agents Revenue in Global Market (2018-2023)
7.18.5 Camber Pharmaceutical Key News & Latest Developments
7.19 Major Pharmaceuticals
7.19.1 Major Pharmaceuticals Company Summary
7.19.2 Major Pharmaceuticals Business Overview
7.19.3 Major Pharmaceuticals Antihypertensive Agents Major Product Offerings
7.19.4 Major Pharmaceuticals Antihypertensive Agents Revenue in Global Market (2018-2023)
7.19.5 Major Pharmaceuticals Key News & Latest Developments
7.20 Glenmark Pharmaceuticals
7.20.1 Glenmark Pharmaceuticals Company Summary
7.20.2 Glenmark Pharmaceuticals Business Overview
7.20.3 Glenmark Pharmaceuticals Antihypertensive Agents Major Product Offerings
7.20.4 Glenmark Pharmaceuticals Antihypertensive Agents Revenue in Global Market (2018-2023)
7.20.5 Glenmark Pharmaceuticals Key News & Latest Developments
7.21 Zydus Pharmaceuticals
7.21.1 Zydus Pharmaceuticals Company Summary
7.21.2 Zydus Pharmaceuticals Business Overview
7.21.3 Zydus Pharmaceuticals Antihypertensive Agents Major Product Offerings
7.21.4 Zydus Pharmaceuticals Antihypertensive Agents Revenue in Global Market (2018-2023)
7.21.5 Zydus Pharmaceuticals Key News & Latest Developments
7.22 Amneal Pharmaceuticals
7.22.1 Amneal Pharmaceuticals Company Summary
7.22.2 Amneal Pharmaceuticals Business Overview
7.22.3 Amneal Pharmaceuticals Antihypertensive Agents Major Product Offerings
7.22.4 Amneal Pharmaceuticals Antihypertensive Agents Revenue in Global Market (2018-2023)
7.22.5 Amneal Pharmaceuticals Key News & Latest Developments
7.23 Endo International
7.23.1 Endo International Company Summary
7.23.2 Endo International Business Overview
7.23.3 Endo International Antihypertensive Agents Major Product Offerings
7.23.4 Endo International Antihypertensive Agents Revenue in Global Market (2018-2023)
7.23.5 Endo International Key News & Latest Developments
7.24 Unichem Laboratories
7.24.1 Unichem Laboratories Company Summary
7.24.2 Unichem Laboratories Business Overview
7.24.3 Unichem Laboratories Antihypertensive Agents Major Product Offerings
7.24.4 Unichem Laboratories Antihypertensive Agents Revenue in Global Market (2018-2023)
7.24.5 Unichem Laboratories Key News & Latest Developments
7.25 Huahai Pharmaceutical
7.25.1 Huahai Pharmaceutical Company Summary
7.25.2 Huahai Pharmaceutical Business Overview
7.25.3 Huahai Pharmaceutical Antihypertensive Agents Major Product Offerings
7.25.4 Huahai Pharmaceutical Antihypertensive Agents Revenue in Global Market (2018-2023)
7.25.5 Huahai Pharmaceutical Key News & Latest Developments
7.26 Shijiazhuang Pharma Group
7.26.1 Shijiazhuang Pharma Group Company Summary
7.26.2 Shijiazhuang Pharma Group Business Overview
7.26.3 Shijiazhuang Pharma Group Antihypertensive Agents Major Product Offerings
7.26.4 Shijiazhuang Pharma Group Antihypertensive Agents Revenue in Global Market (2018-2023)
7.26.5 Shijiazhuang Pharma Group Key News & Latest Developments
7.27 Shanghai Shyndec Pharmaceutical
7.27.1 Shanghai Shyndec Pharmaceutical Company Summary
7.27.2 Shanghai Shyndec Pharmaceutical Business Overview
7.27.3 Shanghai Shyndec Pharmaceutical Antihypertensive Agents Major Product Offerings
7.27.4 Shanghai Shyndec Pharmaceutical Antihypertensive Agents Revenue in Global Market (2018-2023)
7.27.5 Shanghai Shyndec Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Antihypertensive Agents Market Opportunities & Trends in Global Market
Table 2. Antihypertensive Agents Market Drivers in Global Market
Table 3. Antihypertensive Agents Market Restraints in Global Market
Table 4. Key Players of Antihypertensive Agents in Global Market
Table 5. Top Antihypertensive Agents Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Antihypertensive Agents Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Antihypertensive Agents Revenue Share by Companies, 2018-2023
Table 8. Global Companies Antihypertensive Agents Product Type
Table 9. List of Global Tier 1 Antihypertensive Agents Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antihypertensive Agents Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Antihypertensive Agents Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Antihypertensive Agents Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Antihypertensive Agents Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Antihypertensive Agents Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Antihypertensive Agents Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Antihypertensive Agents Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Antihypertensive Agents Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Antihypertensive Agents Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Antihypertensive Agents Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Antihypertensive Agents Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Antihypertensive Agents Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Antihypertensive Agents Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Antihypertensive Agents Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Antihypertensive Agents Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Antihypertensive Agents Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Antihypertensive Agents Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Antihypertensive Agents Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Antihypertensive Agents Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Antihypertensive Agents Revenue, (US$, Mn), 2024-2029
Table 30. Baxter International Company Summary
Table 31. Baxter International Antihypertensive Agents Product Offerings
Table 32. Baxter International Antihypertensive Agents Revenue (US$, Mn) & (2018-2023)
Table 33. Baxter International Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Antihypertensive Agents Product Offerings
Table 36. Pfizer Antihypertensive Agents Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Key News & Latest Developments
Table 38. Sandoz Company Summary
Table 39. Sandoz Antihypertensive Agents Product Offerings
Table 40. Sandoz Antihypertensive Agents Revenue (US$, Mn) & (2018-2023)
Table 41. Sandoz Key News & Latest Developments
Table 42. Teva Pharmaceuticals Company Summary
Table 43. Teva Pharmaceuticals Antihypertensive Agents Product Offerings
Table 44. Teva Pharmaceuticals Antihypertensive Agents Revenue (US$, Mn) & (2018-2023)
Table 45. Teva Pharmaceuticals Key News & Latest Developments
Table 46. Bayer Company Summary
Table 47. Bayer Antihypertensive Agents Product Offerings
Table 48. Bayer Antihypertensive Agents Revenue (US$, Mn) & (2018-2023)
Table 49. Bayer Key News & Latest Developments
Table 50. Johnson & Johnson Company Summary
Table 51. Johnson & Johnson Antihypertensive Agents Product Offerings
Table 52. Johnson & Johnson Antihypertensive Agents Revenue (US$, Mn) & (2018-2023)
Table 53. Johnson & Johnson Key News & Latest Developments
Table 54. Sun Pharmaceutical Industries Company Summary
Table 55. Sun Pharmaceutical Industries Antihypertensive Agents Product Offerings
Table 56. Sun Pharmaceutical Industries Antihypertensive Agents Revenue (US$, Mn) & (2018-2023)
Table 57. Sun Pharmaceutical Industries Key News & Latest Developments
Table 58. Merck Company Summary
Table 59. Merck Antihypertensive Agents Product Offerings
Table 60. Merck Antihypertensive Agents Revenue (US$, Mn) & (2018-2023)
Table 61. Merck Key News & Latest Developments
Table 62. AstraZeneca Company Summary
Table 63. AstraZeneca Antihypertensive Agents Product Offerings
Table 64. AstraZeneca Antihypertensive Agents Revenue (US$, Mn) & (2018-2023)
Table 65. AstraZeneca Key News & Latest Developments
Table 66. Daiichi Sankyo Company Summary
Table 67. Daiichi Sankyo Antihypertensive Agents Product Offerings
Table 68. Daiichi Sankyo Antihypertensive Agents Revenue (US$, Mn) & (2018-2023)
Table 69. Daiichi Sankyo Key News & Latest Developments
Table 70. Takeda Company Summary
Table 71. Takeda Antihypertensive Agents Product Offerings
Table 72. Takeda Antihypertensive Agents Revenue (US$, Mn) & (2018-2023)
Table 73. Takeda Key News & Latest Developments
Table 74. Actelion Company Summary
Table 75. Actelion Antihypertensive Agents Product Offerings
Table 76. Actelion Antihypertensive Agents Revenue (US$, Mn) & (2018-2023)
Table 77. Actelion Key News & Latest Developments
Table 78. Viatris Company Summary
Table 79. Viatris Antihypertensive Agents Product Offerings
Table 80. Viatris Antihypertensive Agents Revenue (US$, Mn) & (2018-2023)
Table 81. Viatris Key News & Latest Developments
Table 82. United Therapeutics Company Summary
Table 83. United Therapeutics Antihypertensive Agents Product Offerings
Table 84. United Therapeutics Antihypertensive Agents Revenue (US$, Mn) & (2018-2023)
Table 85. United Therapeutics Key News & Latest Developments
Table 86. Lupin Limited Company Summary
Table 87. Lupin Limited Antihypertensive Agents Product Offerings
Table 88. Lupin Limited Antihypertensive Agents Revenue (US$, Mn) & (2018-2023)
Table 89. Lupin Limited Key News & Latest Developments
Table 90. Hikma Pharmaceuticals Company Summary
Table 91. Hikma Pharmaceuticals Antihypertensive Agents Product Offerings
Table 92. Hikma Pharmaceuticals Antihypertensive Agents Revenue (US$, Mn) & (2018-2023)
Table 93. Hikma Pharmaceuticals Key News & Latest Developments
Table 94. Aurobindo Pharma Company Summary
Table 95. Aurobindo Pharma Antihypertensive Agents Product Offerings
Table 96. Aurobindo Pharma Antihypertensive Agents Revenue (US$, Mn) & (2018-2023)
Table 97. Aurobindo Pharma Key News & Latest Developments
Table 98. Camber Pharmaceutical Company Summary
Table 99. Camber Pharmaceutical Antihypertensive Agents Product Offerings
Table 100. Camber Pharmaceutical Antihypertensive Agents Revenue (US$, Mn) & (2018-2023)
Table 101. Camber Pharmaceutical Key News & Latest Developments
Table 102. Major Pharmaceuticals Company Summary
Table 103. Major Pharmaceuticals Antihypertensive Agents Product Offerings
Table 104. Major Pharmaceuticals Antihypertensive Agents Revenue (US$, Mn) & (2018-2023)
Table 105. Major Pharmaceuticals Key News & Latest Developments
Table 106. Glenmark Pharmaceuticals Company Summary
Table 107. Glenmark Pharmaceuticals Antihypertensive Agents Product Offerings
Table 108. Glenmark Pharmaceuticals Antihypertensive Agents Revenue (US$, Mn) & (2018-2023)
Table 109. Glenmark Pharmaceuticals Key News & Latest Developments
Table 110. Zydus Pharmaceuticals Company Summary
Table 111. Zydus Pharmaceuticals Antihypertensive Agents Product Offerings
Table 112. Zydus Pharmaceuticals Antihypertensive Agents Revenue (US$, Mn) & (2018-2023)
Table 113. Zydus Pharmaceuticals Key News & Latest Developments
Table 114. Amneal Pharmaceuticals Company Summary
Table 115. Amneal Pharmaceuticals Antihypertensive Agents Product Offerings
Table 116. Amneal Pharmaceuticals Antihypertensive Agents Revenue (US$, Mn) & (2018-2023)
Table 117. Amneal Pharmaceuticals Key News & Latest Developments
Table 118. Endo International Company Summary
Table 119. Endo International Antihypertensive Agents Product Offerings
Table 120. Endo International Antihypertensive Agents Revenue (US$, Mn) & (2018-2023)
Table 121. Endo International Key News & Latest Developments
Table 122. Unichem Laboratories Company Summary
Table 123. Unichem Laboratories Antihypertensive Agents Product Offerings
Table 124. Unichem Laboratories Antihypertensive Agents Revenue (US$, Mn) & (2018-2023)
Table 125. Unichem Laboratories Key News & Latest Developments
Table 126. Huahai Pharmaceutical Company Summary
Table 127. Huahai Pharmaceutical Antihypertensive Agents Product Offerings
Table 128. Huahai Pharmaceutical Antihypertensive Agents Revenue (US$, Mn) & (2018-2023)
Table 129. Huahai Pharmaceutical Key News & Latest Developments
Table 130. Shijiazhuang Pharma Group Company Summary
Table 131. Shijiazhuang Pharma Group Antihypertensive Agents Product Offerings
Table 132. Shijiazhuang Pharma Group Antihypertensive Agents Revenue (US$, Mn) & (2018-2023)
Table 133. Shijiazhuang Pharma Group Key News & Latest Developments
Table 134. Shanghai Shyndec Pharmaceutical Company Summary
Table 135. Shanghai Shyndec Pharmaceutical Antihypertensive Agents Product Offerings
Table 136. Shanghai Shyndec Pharmaceutical Antihypertensive Agents Revenue (US$, Mn) & (2018-2023)
Table 137. Shanghai Shyndec Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Antihypertensive Agents Segment by Type in 2022
Figure 2. Antihypertensive Agents Segment by Application in 2022
Figure 3. Global Antihypertensive Agents Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Antihypertensive Agents Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Antihypertensive Agents Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antihypertensive Agents Revenue in 2022
Figure 8. By Type - Global Antihypertensive Agents Revenue Market Share, 2018-2029
Figure 9. By Application - Global Antihypertensive Agents Revenue Market Share, 2018-2029
Figure 10. By Type - Global Antihypertensive Agents Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Antihypertensive Agents Revenue Market Share, 2018-2029
Figure 12. By Application - Global Antihypertensive Agents Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Antihypertensive Agents Revenue Market Share, 2018-2029
Figure 14. By Region - Global Antihypertensive Agents Revenue Market Share, 2018-2029
Figure 15. By Country - North America Antihypertensive Agents Revenue Market Share, 2018-2029
Figure 16. US Antihypertensive Agents Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Antihypertensive Agents Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Antihypertensive Agents Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Antihypertensive Agents Revenue Market Share, 2018-2029
Figure 20. Germany Antihypertensive Agents Revenue, (US$, Mn), 2018-2029
Figure 21. France Antihypertensive Agents Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Antihypertensive Agents Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Antihypertensive Agents Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Antihypertensive Agents Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Antihypertensive Agents Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Antihypertensive Agents Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Antihypertensive Agents Revenue Market Share, 2018-2029
Figure 28. China Antihypertensive Agents Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Antihypertensive Agents Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Antihypertensive Agents Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Antihypertensive Agents Revenue, (US$, Mn), 2018-2029
Figure 32. India Antihypertensive Agents Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Antihypertensive Agents Revenue Market Share, 2018-2029
Figure 34. Brazil Antihypertensive Agents Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Antihypertensive Agents Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Antihypertensive Agents Revenue Market Share, 2018-2029
Figure 37. Turkey Antihypertensive Agents Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Antihypertensive Agents Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Antihypertensive Agents Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Antihypertensive Agents Revenue, (US$, Mn), 2018-2029
Figure 41. Baxter International Antihypertensive Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Antihypertensive Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Sandoz Antihypertensive Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Teva Pharmaceuticals Antihypertensive Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bayer Antihypertensive Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Johnson & Johnson Antihypertensive Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Sun Pharmaceutical Industries Antihypertensive Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Merck Antihypertensive Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. AstraZeneca Antihypertensive Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Daiichi Sankyo Antihypertensive Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Takeda Antihypertensive Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Actelion Antihypertensive Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Viatris Antihypertensive Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. United Therapeutics Antihypertensive Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Lupin Limited Antihypertensive Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Hikma Pharmaceuticals Antihypertensive Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Aurobindo Pharma Antihypertensive Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Camber Pharmaceutical Antihypertensive Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Major Pharmaceuticals Antihypertensive Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Glenmark Pharmaceuticals Antihypertensive Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Zydus Pharmaceuticals Antihypertensive Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. Amneal Pharmaceuticals Antihypertensive Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 63. Endo International Antihypertensive Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 64. Unichem Laboratories Antihypertensive Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 65. Huahai Pharmaceutical Antihypertensive Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 66. Shijiazhuang Pharma Group Antihypertensive Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 67. Shanghai Shyndec Pharmaceutical Antihypertensive Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
